相关实验视频

Updated: Jul 24, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

用于癌症免疫治疗的IPSC衍生的CAR-NK细胞

Xiaotong Lin¹, Yao Sun², Xin Dong²

¹Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|July 5, 2023

概括

来自诱导多能干细胞 (iPSC) 的化学抗原受体 (CAR) -自然杀手 (NK) 细胞提供了一个有前途的"现成"癌症免疫疗法. 本综述探讨了CAR-iNK细胞制造,证据和未来前景.

科学领域:

免疫治疗是一种免疫疗法.
细胞疗法细胞疗法
癌症研究癌症研究

背景情况:

化学抗原受体 (CAR) -T细胞疗法已经推进了癌症治疗,FDA批准的产品用于血液恶性瘤.
与CAR-T细胞相比,CAR-NK细胞因其安全性提高,杀死机制多样化以及更广泛的可访问性而受到关注.
诱导多能干细胞衍生NK (iPSC-NK) 细胞为CAR-NK细胞发育提供了一个成熟,强大和可扩展的来源.

研究的目的:

审查CAR-iNK细胞的制造技术和基因修饰策略.
总结前临床和临床证据,支持CAR-iNK细胞治疗的疗效.
讨论癌症免疫治疗中CAR-iNK细胞治疗的挑战和未来方向.

主要方法:

关于CAR-NK和CAR-iNK细胞发育的科学文献的审查.
对iPSC-NK细胞扩张和基因工程的制造工艺的分析.
关于CAR-iNK细胞治疗的临床前和临床数据的综合.

主要成果:

iPSC-NK细胞为CAR-NK疗法提供了一个标准化,可扩展和潜在的"现成"产品.
CAR-iNK细胞利用多种杀死机制和有利的安全性.
有证据表明,CAR-iNK细胞对各种癌症类型具有显著的潜力.

结论:

CAR-iNK细胞代表了一种新且有前途的癌症细胞免疫疗法.
需要进一步的研究和临床试验来克服制造和临床挑战.
CAR-iNK细胞疗法即将成为未来癌症治疗策略中的关键参与者.

关键词:

化学抗原受体的化学抗原受体免疫疗法是一种免疫疗法.诱导的多能干细胞干细胞.自然杀手细胞是什么?

更多相关视频

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...